Literature DB >> 22813361

Cardiovascular imaging and diagnostic procedures in pregnancy.

David L Ain1, Jagat Narula, Partho P Sengupta.   

Abstract

Diagnostic imaging procedures, including echocardiography, chest radiography, angiography, CT, and cardiovascular MRI, may be indicated in pregnant patients. Concerns related to the safety of these tests must be balanced against the importance of accurate diagnosis and assessment of a pathologic state. Such a calculation requires an understanding of the normal physiology of pregnancy, manifestations of pre-existing cardiac disease in pregnant women, and signs and symptoms of nascent cardiovascular disease. Additionally cardiologists must understand indications for and limitations of each diagnostic imaging test, potential harmful effects of various modalities, and precautions that must be taken to protect the fetus.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22813361     DOI: 10.1016/j.ccl.2012.05.002

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  4 in total

1.  Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women.

Authors:  Dana Meaney-Delman; Marianne E Zotti; Andreea A Creanga; Lara K Misegades; Etobssie Wako; Tracee A Treadwell; Nancy E Messonnier; Denise J Jamieson
Journal:  Emerg Infect Dis       Date:  2014-02       Impact factor: 6.883

Review 2.  Role of echocardiography in the management of cardiac disease in women.

Authors:  Wan Joo Shim
Journal:  J Cardiovasc Ultrasound       Date:  2014-12-26

Review 3.  Diagnosing cardiac disease during pregnancy: imaging modalities.

Authors:  Ntobeko A Ntusi; Petronella Samuels; Sulaiman Moosa; Ana O Mocumbi
Journal:  Cardiovasc J Afr       Date:  2016 Mar-Apr       Impact factor: 1.167

4.  Peripartum women with dyspnea in the emergency department: Is it peripartum cardiomyopathy?

Authors:  Wei-Wei Wang; Yu Wang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.